Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS‐CoV‐2 infection
Open Access
- 26 August 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (1), 178-185
- https://doi.org/10.1002/jmv.27290
Abstract
Many aspects of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as its role in protection after natural infection, are still unclear. We evaluated IgA and IgG response to spike subunits 1 and 2 (S1 and S2) and Nucleocapsid proteins of SARS-COV-2 in serum samples of 109 volunteers with viral RNA detected or seroconversion with different clinical evolution (asymptomatic, mild, moderate, and severe coronavirus disease 2019), using the ViraChip® Test Kit. We observed that the quantification of antibodies to all antigens had a positive correlation to disease severity, which was strongly associated with the presence of comorbidities. Seroreversion was not uncommon even during the short (median of 77 days) observation, occurring in 15% of mild-asymptomatic cases at a median of 55 days for IgG and 46 days for IgA. The time to reach the maximal antibody response did not differ significantly among recovered and deceased volunteers. Our study illustrated the dynamic of anti-S1, anti-N, and anti-S2 IgA and IgG antibodies, and suggests that high production of IgG and IgA does not guarantee protection to disease severity and that functional responses that have been studied by other groups, such as antibody avidity, need further attention.Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 30 references indexed in Scilit:
- Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationshipsObesity Reviews, 2020
- Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalImmunity, 2020
- Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysisAging, 2020
- Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, ChinaEuropean Urology, 2020
- COVID-19: Unanswered questions on immune response and pathogenesisJournal of Allergy and Clinical Immunology, 2020
- COVID-19: The first documented coronavirus pandemic in historyBiomedical Journal, 2020
- Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Manipulation of the Innate Immune Response by Varicella Zoster VirusFrontiers in Immunology, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020